Table 2.
Ethnicity/Race | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | Hispanic | African American/ Black | White | Asian American/ Pacific Islander | |||||||||||
Men | Women | Total | Men | Women | Total | Men | Women | Total | Men | Women | Total | Men | Women | Total | |
N (%) | |||||||||||||||
Probable ED | 140 (29.7%) | 172 (35.8%) | 312 (32.7%) | 47 (39.5%) | 48 (42.1%) | 95 (40.8%) | 26 (22.6) | 42 (35.9%) | 68 (29.3%) | 36 (31.6%) | 39 (31.2%) | 75 (31.4%) | 31 (25.2%) | 42 (33.9%) | 73 (29.6%) |
Probable BDD | 249 (52.1%) | 240 (49.7%) | 489 (50.9%) | 83 (69.2%) | 70 (61.4%) | 153 (65.4%) | 50 (42.7%) | 59 (50.0%) | 109 (46.4%) | 67 (57.8%) | 57 (45.6%) | 124 (51.5%) | 49 (39.5%) | 53 (42.4%) | 102 (41%) |
APED misuse | 171 (35.7%) | 123 (25.5%) | 294 (30.6%) | 62 (51.7%) | 41 (36.0%) | 103 (44.0%) | 42 (35.6%) | 42 (35.6%) | 84 (35.6%) | 37 (31.9%) | 23 (18.4%) | 60 (24.9%) | 29 (23.4%) | 17 (13.6%) | 46 (18.5%) |
Note. N = number of participants, ED = eating disorders, BDD = body dysmorphic disorder, APED = appearance and performance enhancement drug